Vnitr Lek 2020, 66(8):e28-e33 | DOI: 10.36290/vnl.2020.155

Dialysis patient in internal medicine inpatient ward

Petr Táborský
Fresenius Medical Care, Praha

Chronic kidney disease has been recognized as a worldwide epidemic. Its prevalence in developed countries is about 10 %, the number of patients treated by dialysis is on average 1.000 person per 1 million of population. Kidney failure is associated with high mortality due to high prevalence of cardiovascular disease. Cardiovascular risk factors differ in renal patients and general population. Most important of them are chronic overhydratation, anemia, disturbed calcium-phosphate metabolism, uremic toxins and protein-calorie malnutrition. Hospitalization of dialysis patient in internal medicine ward has some specific problems including dialysis tactics, care of vascular access and inpatient logistics. Dialysis tactics is expressed in dialysis prescription, where the ultrafiltration, anticoagulation and dialysate composition must be carefully planned. Peripheral veins should be saved for future vascular access, early diagnostics of thrombotic and infectious complications is necessary. Proper timing of blood sampling for laboratory investigation and drug administration must be related to dialysis schedule. Effective communication between inpatient ward and dialysis unit is essential.

Keywords: dialysis, hospitalization, chronic kidney disease.

Published: December 15, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Táborský P. Dialysis patient in internal medicine inpatient ward. Vnitr Lek. 2020;66(8):e28-33. doi: 10.36290/vnl.2020.155.
Download citation

References

  1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: (2 Suppl. 1): S1-266.
  2. Couser WG, Remuzzi G, Mendis S, et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011; 80: 1258-1270. Go to original source... Go to PubMed...
  3. Obrador GT, Pereira BJ, Kausz AT. Chronic kidney disease in the United States: an underrecognized problem. Semin Nephrol 2002; 22: 441-448. Go to original source... Go to PubMed...
  4. Brück K, Stel VS, Gambaro G, et al. CKD Prevalence Varies across the European General Population. European CKD Burden Consortium. J Am Soc Nephrol 2016; 27: 2135-2147. Go to original source... Go to PubMed...
  5. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. Kidney Int Suppl 2013; 3: 1-150.
  6. WHO Diabetes country profiles 2016. http://www.who.int/diabetes/country‑profiles/en/#C
  7. Statistická ročenka dialyzační léčby v České republice, web České nefrologické společnosti, http://www.nefrol.cz/odbornici/dialyzacni‑statistikaPruthi R, Casula A, MacPhee I UK Renal Registry 18th Annual Report: Chapter 3 Demographic and Biochemistry Profile of Kidney Transplant Recipients in the UK in 2014: National and Centre‑specific Analyses. Nephron 2016; 132: (Suppl. 1): 69-98. Go to PubMed...
  8. United States Renal Data System, 2017 Annual Data Report, https://www.usrds.org/adr.aspx
  9. Mortality and global health estimates. http://www.who.int/en/news‑room/fact‑sheets/detail/the‑top-10-causes‑of‑death
  10. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-1615. Go to original source... Go to PubMed...
  11. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305. Go to original source... Go to PubMed...
  12. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-495. Go to original source... Go to PubMed...
  13. Kalantar‑Zadeh K, Block G, Humphreys MH, et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808. Go to original source... Go to PubMed...
  14. Wabel P, Moissl U, Chamney P, et al. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 23: 2965-2971. Go to original source... Go to PubMed...
  15. Walker AM, Schneider G, Yeaw J, et al. Anemia as a predictor of cardiovascular events in patients with elevated serum creatinine. J Am Soc Nephrol 2006; 17: 2293-2298. Go to original source... Go to PubMed...
  16. Hruska KA, Sugatani T, Agapova O, et al. The chronic kidney disease - Mineral bone disorder (CKD‑MBD): Advances in pathophysiology. Bone 2017; 100: 80-86. Go to original source... Go to PubMed...
  17. Dai L, Golembiewska E, Lindholm B et al. End‑Stage Renal Disease, Inflammation and Cardiovascular Outcomes. Contrib Nephrol 2017; 191: 32-43. Go to original source... Go to PubMed...
  18. Ikizler TA, Cano NJ, Franch H, et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int 2013; 84: 1096-1107. Go to original source... Go to PubMed...
  19. Gilbert SJ, Weiner DE, Bomback AS, et al. National Kidney Foundation's Primer on Kidney Diseases, 7. vydání, Elsevier 2017.
  20. Nissenson A, Fine R. Handbook of Dialysis Therapy, 5. vydání, Elsevier 2016.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.